Form 8-K Pulse Biosciences, Inc. For: Oct 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Pulse Biosciences, Inc. (PLSE) Reports Q3 Loss of $0.64
October 30, 2018 4:40 PM EDTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.64).
Were pleased with the continued and significant progress weve made and are making towards bringing our NPS platform closer to commercialization, said Darrin Uecker, Pulse Biosciences President and Chief Executive Officer. Our data... More



